Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 2/2016

01-10-2016

Angioedema Phenotypes: Disease Expression and Classification

Authors: Maddalena Alessandra Wu, Francesca Perego, Andrea Zanichelli, Marco Cicardi

Published in: Clinical Reviews in Allergy & Immunology | Issue 2/2016

Login to get access

Abstract

Due to marked heterogeneity of clinical presentations, comprehensive knowledge of angioedema phenotypes is crucial for correct diagnosis and choosing the appropriate therapeutic approach. One of the ways to a meaningful clinical distinction can be made between forms of angioedema occurring “with or without wheals.” Angioedema with wheals (rash) is a hallmark of urticaria, either acute or chronic, spontaneous or inducible. Angioedema without wheals may still be manifested in about 10 % of patients with urticaria, but it may also occur as a separate entity. Several classifications of angioedema as part of urticaria were published over time, while a latest one, released in 2014 (HAWK group consensus, see below), provided a classification of all forms of “angioedema without wheals” distinct from urticaria, which will be the focus of the present review. At this time, the HAWK consensus classification is the best in terms of covering the pathophysiology, mediators involved, angioedema triggers, and clinical expression. According to this classification, three types of hereditary angioedema (genetic C1-INH deficiency, normal C1-INH with factor XII mutations, and unknown origin) and four types of acquired angioedema (C1-INH deficiency, related to ACE inhibitors intake, idiopathic histaminergic, and idiopathic non-histaminergic) are presented. We will review the distinctive clinical features of each phenotype in details.
Literature
1.
go back to reference Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT (2010) The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 31:407–14CrossRefPubMed Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT (2010) The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 31:407–14CrossRefPubMed
2.
go back to reference Quincke H (1882) Uber akutes umschriebened hautodem. Monatshe Prakt Dermatol 1:129–131 Quincke H (1882) Uber akutes umschriebened hautodem. Monatshe Prakt Dermatol 1:129–131
3.
4.
go back to reference Vestergaard C, Deleuran M (2015) Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy. Ther Adv Chronic Dis 6:304–13CrossRefPubMedPubMedCentral Vestergaard C, Deleuran M (2015) Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy. Ther Adv Chronic Dis 6:304–13CrossRefPubMedPubMedCentral
5.
go back to reference Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW et al (2014) The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868–87CrossRefPubMed Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW et al (2014) The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868–87CrossRefPubMed
6.
go back to reference Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69:602–16CrossRefPubMed Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69:602–16CrossRefPubMed
7.
go back to reference Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A et al (2012) Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc 33(Suppl 1):S145–56CrossRefPubMed Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A et al (2012) Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc 33(Suppl 1):S145–56CrossRefPubMed
8.
9.
go back to reference Cugno M, Nussberger J, Cicardi M, Agostoni A (2003) Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3:311–7CrossRefPubMed Cugno M, Nussberger J, Cicardi M, Agostoni A (2003) Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3:311–7CrossRefPubMed
10.
go back to reference Defendi F, Charignon D, Ghannam A, Baroso R, Csopaki F, Allegret-Cadet M et al (2013) Enzymatic assays for the diagnosis of bradykinin-dependent angioedema. PLoS One 8, e70140CrossRefPubMedPubMedCentral Defendi F, Charignon D, Ghannam A, Baroso R, Csopaki F, Allegret-Cadet M et al (2013) Enzymatic assays for the diagnosis of bradykinin-dependent angioedema. PLoS One 8, e70140CrossRefPubMedPubMedCentral
11.
go back to reference Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A (1999) Idiopathic nonhistaminergic angioedema. Am J Med 106:650–4CrossRefPubMed Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A (1999) Idiopathic nonhistaminergic angioedema. Am J Med 106:650–4CrossRefPubMed
12.
go back to reference Du-Thanh A, Raison-Peyron N, Drouet C, Guillot B (2010) Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. Allergy 65:793–5CrossRefPubMed Du-Thanh A, Raison-Peyron N, Drouet C, Guillot B (2010) Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. Allergy 65:793–5CrossRefPubMed
13.
go back to reference Del Corso I, Puxeddu I, Sardano E, Geraci S, Breggia M, Rocchi V et al (2012) Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant. Ann Allergy Asthma Immunol 108:460–1CrossRefPubMed Del Corso I, Puxeddu I, Sardano E, Geraci S, Breggia M, Rocchi V et al (2012) Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant. Ann Allergy Asthma Immunol 108:460–1CrossRefPubMed
14.
go back to reference Colas C, Montoiro R, Fraj J, Garces M, Cubero JL, Caballero T (2012) Nonhistaminergic idiopathic angioedema: clinical response to icatibant. J Investig Allergol Clin Immunol 22:520–1PubMed Colas C, Montoiro R, Fraj J, Garces M, Cubero JL, Caballero T (2012) Nonhistaminergic idiopathic angioedema: clinical response to icatibant. J Investig Allergol Clin Immunol 22:520–1PubMed
15.
16.
go back to reference Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK et al (2010) Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 56:278–82CrossRefPubMed Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK et al (2010) Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 56:278–82CrossRefPubMed
17.
go back to reference Bova M, Guilarte M, Sala-Cunill A, Borrelli P, Rizzelli GM, Zanichelli A (2015) Treatment of ACEI-related angioedema with icatibant: a case series. Intern Emerg Med 10:345–50CrossRefPubMed Bova M, Guilarte M, Sala-Cunill A, Borrelli P, Rizzelli GM, Zanichelli A (2015) Treatment of ACEI-related angioedema with icatibant: a case series. Intern Emerg Med 10:345–50CrossRefPubMed
18.
go back to reference Bas M, Greve J, Stelter K, Havel M, Strassen U, Rotter N et al (2015) A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med 372:418–25CrossRefPubMed Bas M, Greve J, Stelter K, Havel M, Strassen U, Rotter N et al (2015) A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med 372:418–25CrossRefPubMed
19.
go back to reference Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M (2006) First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 118:1330–5CrossRefPubMed Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M (2006) First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 118:1330–5CrossRefPubMed
20.
go back to reference Lopez-Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, Lopez-Trascasa M (2010) A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy Clin Immunol 126:1307–10 e3CrossRefPubMed Lopez-Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, Lopez-Trascasa M (2010) A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy Clin Immunol 126:1307–10 e3CrossRefPubMed
22.
go back to reference Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A et al (2000) Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 106:1147–54CrossRefPubMed Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A et al (2000) Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 106:1147–54CrossRefPubMed
23.
go back to reference Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M et al (2015) A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis 10:11CrossRefPubMedPubMedCentral Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M et al (2015) A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis 10:11CrossRefPubMedPubMedCentral
24.
go back to reference Bork K, Meng G, Staubach P, Hardt J (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119:267–74CrossRefPubMed Bork K, Meng G, Staubach P, Hardt J (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119:267–74CrossRefPubMed
26.
go back to reference Xu YY, Zhi YX, Yin J, Wang LL, Wen LP, Gu JQ et al (2012) Mutational spectrum and geno-phenotype correlation in Chinese families with hereditary angioedema. Allergy 67:1430–6CrossRefPubMed Xu YY, Zhi YX, Yin J, Wang LL, Wen LP, Gu JQ et al (2012) Mutational spectrum and geno-phenotype correlation in Chinese families with hereditary angioedema. Allergy 67:1430–6CrossRefPubMed
27.
go back to reference Bygum A, Fagerberg CR, Ponard D, Monnier N, Lunardi J, Drouet C (2011) Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency. Allergy 66:76–84CrossRefPubMed Bygum A, Fagerberg CR, Ponard D, Monnier N, Lunardi J, Drouet C (2011) Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency. Allergy 66:76–84CrossRefPubMed
28.
go back to reference Lopez-Lera A, Cabo FS, Garrido S, Dopazo A, Lopez-Trascasa M (2013) Disease-modifying factors in hereditary angioedema: an RNA expression-based screening. Orphanet J Rare Dis 8:77CrossRefPubMedPubMedCentral Lopez-Lera A, Cabo FS, Garrido S, Dopazo A, Lopez-Trascasa M (2013) Disease-modifying factors in hereditary angioedema: an RNA expression-based screening. Orphanet J Rare Dis 8:77CrossRefPubMedPubMedCentral
29.
go back to reference Speletas M, Szilagyi A, Psarros F, Moldovan D, Magerl M, Kompoti M et al (2015) Hereditary angioedema: molecular and clinical differences among European populations. J Allergy Clin Immunol 135:570–3CrossRefPubMed Speletas M, Szilagyi A, Psarros F, Moldovan D, Magerl M, Kompoti M et al (2015) Hereditary angioedema: molecular and clinical differences among European populations. J Allergy Clin Immunol 135:570–3CrossRefPubMed
30.
go back to reference Andrejevic S, Korosec P, Silar M, Kosnik M, Mijanovic R, Bonaci-Nikolic B et al (2015) Hereditary angioedema due to C1 inhibitor deficiency in Serbia: two novel mutations and evidence of genotype-phenotype association. PLoS One 10, e0142174CrossRefPubMedPubMedCentral Andrejevic S, Korosec P, Silar M, Kosnik M, Mijanovic R, Bonaci-Nikolic B et al (2015) Hereditary angioedema due to C1 inhibitor deficiency in Serbia: two novel mutations and evidence of genotype-phenotype association. PLoS One 10, e0142174CrossRefPubMedPubMedCentral
31.
go back to reference Martinez‐Saguer I, Gutowski Z, Andritschke K, Csuka D, Kőhalmi KV, Varga L, Farkas H (2015) Inter individual variations in symptom expression and clinical course in monozygotic twins with hereditary angioedema type I. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 55 Martinez‐Saguer I, Gutowski Z, Andritschke K, Csuka D, Kőhalmi KV, Varga L, Farkas H (2015) Inter individual variations in symptom expression and clinical course in monozygotic twins with hereditary angioedema type I. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 55
32.
go back to reference Leibovich I, Golander H, Somech R, Reshef A (2015) The relationship between premonitory signs and symptoms (“prodromes”) and the onset of hereditary angioedema attacks. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 61 Leibovich I, Golander H, Somech R, Reshef A (2015) The relationship between premonitory signs and symptoms (“prodromes”) and the onset of hereditary angioedema attacks. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 61
33.
go back to reference Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M (2014) High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Clin Exp Allergy 44:1503–14CrossRefPubMed Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M (2014) High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Clin Exp Allergy 44:1503–14CrossRefPubMed
34.
go back to reference Grumach AS, Veronez CL, Cagini N, Stieber C, Nicolicht P, Constantino‐Silva RN, Gonçalves RF, Cordeiro E, Komninakis S, Cichon S, Pesquero JB (2015) Hereditary angioedema without c1 inhibitor deficiency: evaluation of 21 families. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 63 Grumach AS, Veronez CL, Cagini N, Stieber C, Nicolicht P, Constantino‐Silva RN, Gonçalves RF, Cordeiro E, Komninakis S, Cichon S, Pesquero JB (2015) Hereditary angioedema without c1 inhibitor deficiency: evaluation of 21 families. In: Abstracts of the 9th C1-inhibitor deficiency workshop, Budapest, Hungary, 28–31 May 2015. J Angioedema, p 63
36.
go back to reference Zingale LC, Castelli R, Zanichelli A, Cicardi M (2006) Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin N Am 26(4):669–90CrossRef Zingale LC, Castelli R, Zanichelli A, Cicardi M (2006) Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin N Am 26(4):669–90CrossRef
37.
go back to reference Cicardi M, Zanichelli A (2010) The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema. Curr Mol Med 10:354–60CrossRefPubMed Cicardi M, Zanichelli A (2010) The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema. Curr Mol Med 10:354–60CrossRefPubMed
38.
go back to reference Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C (2003) Clinical and biological distinctions between type I and type II acquired angioedema. Am J Med 115:420–1CrossRefPubMed Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C (2003) Clinical and biological distinctions between type I and type II acquired angioedema. Am J Med 115:420–1CrossRefPubMed
39.
go back to reference Schreiber AD, Zweiman B, Atkins P, Goldwein F, Pietra G, Atkinson B et al (1976) Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood 48:567–80PubMed Schreiber AD, Zweiman B, Atkins P, Goldwein F, Pietra G, Atkinson B et al (1976) Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood 48:567–80PubMed
40.
go back to reference Jackson J, Sim RB, Whelan A, Feighery C (1986) An IgG autoantibody which inactivates C1-inhibitor. Nature 323:722–4CrossRefPubMed Jackson J, Sim RB, Whelan A, Feighery C (1986) An IgG autoantibody which inactivates C1-inhibitor. Nature 323:722–4CrossRefPubMed
41.
go back to reference Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M (2007) Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica 92:716–8CrossRefPubMed Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M (2007) Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica 92:716–8CrossRefPubMed
42.
go back to reference Wu MA, Castelli R (2016) The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clin Chem Lab Med 54:207–14PubMed Wu MA, Castelli R (2016) The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clin Chem Lab Med 54:207–14PubMed
43.
go back to reference Castelli R, Wu MA, Arquati M, Zanichelli A, Suffritti C, Rossi D et al (2016) High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. Br J Haematol. doi:10.1111/bjh.13908 Castelli R, Wu MA, Arquati M, Zanichelli A, Suffritti C, Rossi D et al (2016) High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. Br J Haematol. doi:10.​1111/​bjh.​13908
44.
go back to reference Alsenz J, Lambris JD, Bork K, Loos M (1989) Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients’ C1-INH and anti-C1-INH autoantibodies. J Clin Invest 83:1794–9CrossRefPubMedPubMedCentral Alsenz J, Lambris JD, Bork K, Loos M (1989) Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients’ C1-INH and anti-C1-INH autoantibodies. J Clin Invest 83:1794–9CrossRefPubMedPubMedCentral
45.
go back to reference Burkhart DG, Brown NJ, Griffin MR, Ray WA, Hammerstrom T, Weiss S (1996) Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites. Pharmacoepidemiol Drug Saf 5:149–54CrossRefPubMed Burkhart DG, Brown NJ, Griffin MR, Ray WA, Hammerstrom T, Weiss S (1996) Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites. Pharmacoepidemiol Drug Saf 5:149–54CrossRefPubMed
46.
go back to reference Brown NJ, Ray WA, Snowden M, Griffin MR (1996) Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 60:8–13CrossRefPubMed Brown NJ, Ray WA, Snowden M, Griffin MR (1996) Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 60:8–13CrossRefPubMed
47.
go back to reference Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J et al (2005) Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165:1637–42CrossRefPubMed Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J et al (2005) Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165:1637–42CrossRefPubMed
48.
go back to reference Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE (2008) Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51:1624–30CrossRefPubMed Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE (2008) Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51:1624–30CrossRefPubMed
49.
go back to reference Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS et al (2012) Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110:383–91CrossRefPubMed Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS et al (2012) Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110:383–91CrossRefPubMed
50.
go back to reference Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffre D, Nussberger J (1999) Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 44:21–5CrossRefPubMed Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffre D, Nussberger J (1999) Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 44:21–5CrossRefPubMed
51.
go back to reference Campo P, Fernandez TD, Canto G, Mayorga C (2013) Angioedema induced by angiotensin-converting enzyme inhibitors. Curr Opin Allergy Clin Immunol 13:337–44CrossRefPubMed Campo P, Fernandez TD, Canto G, Mayorga C (2013) Angioedema induced by angiotensin-converting enzyme inhibitors. Curr Opin Allergy Clin Immunol 13:337–44CrossRefPubMed
52.
go back to reference Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M (2011) Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 29:2273–7CrossRefPubMed Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M (2011) Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 29:2273–7CrossRefPubMed
53.
go back to reference Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH et al (1988) Clinical profile of angioedema associated with angiotensin converting- enzyme inhibition. JAMA 260:967–70CrossRefPubMed Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH et al (1988) Clinical profile of angioedema associated with angiotensin converting- enzyme inhibition. JAMA 260:967–70CrossRefPubMed
54.
go back to reference Dean DE, Schultz DL, Powers RH (2001) Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 46:1239–43CrossRefPubMed Dean DE, Schultz DL, Powers RH (2001) Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 46:1239–43CrossRefPubMed
55.
go back to reference Dobbels P, Van Overbeke L, Vanbeckevoort D, Hiele M (2009) Acute abdomen due to intestinal angioedema induced by ACE inhibitors: not so rare? Acta Gastroenterol Belg 72:455–7PubMed Dobbels P, Van Overbeke L, Vanbeckevoort D, Hiele M (2009) Acute abdomen due to intestinal angioedema induced by ACE inhibitors: not so rare? Acta Gastroenterol Belg 72:455–7PubMed
57.
go back to reference Mansi M, Zanichelli A, Coerezza A, Suffritti C, Wu MA, Vacchini R et al (2015) Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med 277:585–93CrossRefPubMed Mansi M, Zanichelli A, Coerezza A, Suffritti C, Wu MA, Vacchini R et al (2015) Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med 277:585–93CrossRefPubMed
Metadata
Title
Angioedema Phenotypes: Disease Expression and Classification
Authors
Maddalena Alessandra Wu
Francesca Perego
Andrea Zanichelli
Marco Cicardi
Publication date
01-10-2016
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 2/2016
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-016-8541-z

Other articles of this Issue 2/2016

Clinical Reviews in Allergy & Immunology 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.